{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:22:13Z","timestamp":1777522933024,"version":"3.51.4"},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1818,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0781.2010.00540.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T21:55:20Z","timestamp":1284501320000},"page":"230-234","source":"Crossref","is-referenced-by-count":34,"title":["Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study"],"prefix":"10.1111","volume":"26","author":[{"given":"Imran","family":"Majid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","article-title":"Vitiligo","volume":"38","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB2|cit2","first-page":"573","article-title":"Psychiatric morbidity in vitiligo","volume":"16","author":"Mattoo","year":"2002","journal-title":"prevalence and correlates in India"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB3|cit3","first-page":"8","article-title":"DLQI scores in vitiligo","volume":"4","author":"Aghaei","year":"2004","journal-title":"reliability and validity of the Persian version"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB4|cit4","first-page":"1532","article-title":"Nonsurgical repigmentation therapies in vitiligo","volume":"134","author":"Njoo","year":"1998","journal-title":"meta-analysis of the literature"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1067\/mjd.2001.114752","article-title":"Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo","volume":"44","author":"Scherschun","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalised vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-3083.2006.01546.x","article-title":"Combination of narrow-band UVB and topical calcipotriol for the treatment of vitiligo","volume":"20","author":"Goktas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0781.2005.00139.x","article-title":"No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalised vitiligo","volume":"21","author":"Ada","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB10|cit10","first-page":"223","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure","volume":"190","author":"Schallreuter","year":"1995","journal-title":"a case study on 33 patients"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB11|cit11","first-page":"14","article-title":"The efficacy of 1% pimecrolimus cream plus ultraviolet B in the treatment of vitiligo","volume":"20","author":"Esfanduarpour","year":"2009","journal-title":"a double-blind, placebo-controlled clinical trial"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB12|cit12","first-page":"916","article-title":"Narrowband UVB phototherapy combined with tacrolimus ointment in vitiligo","volume":"21","author":"Fai","year":"2007","journal-title":"a review of 110 patients"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB14|cit14","first-page":"52","article-title":"Topical tacrolimus therapy for vitiligo","volume":"51","author":"Grimes","year":"2004","journal-title":"therapeutic responses and skin messenger RNA expression of proinflammatory cytokines"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB15|cit15","first-page":"498","article-title":"FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes","volume":"153","author":"Lan","year":"2005","journal-title":"possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","article-title":"Efficay and safety of tacrolimus cream 0.1% in the treatment of vitiligo","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB18|cit18","first-page":"760","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children","volume":"51","author":"Silverberg","year":"2004","journal-title":"a review of 57 cases"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0\u00b71% tacrolimus vs. 0\u00b705% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB20|cit20","first-page":"677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool","volume":"140","author":"Hamzavi","year":"2004","journal-title":"the vitiligo area scoring index"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB21|cit21","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo","volume":"30","author":"Kawalek","year":"2004","journal-title":"a pilot study"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB22|cit22","first-page":"1065","article-title":"Topical tacrolimus and the 308-nm excimer laser","volume":"140","author":"Passeron","year":"2004","journal-title":"a synergistic combination for the treatment of vitiligo"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.0022-202X.2005.23858.x","article-title":"Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B radiation","volume":"125","author":"Yarosh","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1600-0781.2010.00540.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jdermsci.2007.11.013","article-title":"Tacrolimus ointment neither blocks ultraviolet B nor affects expression of thymine dimers and p53 in human skin","volume":"50","author":"Gambichler","year":"2008","journal-title":"J Dermatol Sci"}],"container-title":["Photodermatology, Photoimmunology & Photomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0781.2010.00540.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0781.2010.00540.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:49:07Z","timestamp":1625665747000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0781.2010.00540.x"}},"subtitle":["Topical tacrolimus and narrowband UVB combination"],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":24,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0781.2010.00540.x","relation":{},"ISSN":["0905-4383"],"issn-type":[{"value":"0905-4383","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}